Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s00262-018-2197-x/fulltext.html
Reference29 articles.
1. Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette–Guerin in the treatment of superficial bladder tumors. J Urol 116:180–183
2. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, Sylvester RJ, Kaasinen E, Bohle A, Palou Redorta J, Roupret M (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64:639–653
3. Gontero P, Bohle A, Malmstrom PU, O’Donnell MA, Oderda M, Sylvester R, Witjes F (2010) The role of bacillus Calmette–Guerin in the treatment of non-muscle-invasive bladder cancer. Eur Urol 57:410–429
4. Herr HW, Morales A (2008) History of bacillus Calmette–Guerin and bladder cancer: an immunotherapy success story. J Urol 179:53–56
5. Zuiverloon TC, Nieuweboer AJ, Vekony H, Kirkels WJ, Bangma CH, Zwarthoff EC (2012) Markers predicting response to bacillus Calmette–Guerin immunotherapy in high-risk bladder cancer patients: a systematic review. Eur Urol 61:128–145
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Phase 2 Study of S-588410 Maintenance Monotherapy for Platinum-Treated Advanced or Metastatic Urothelial Carcinoma;Bladder Cancer;2022-06-03
2. Emerging treatment landscape of non-muscle invasive bladder cancer;Expert Opinion on Biological Therapy;2022-05-31
3. Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?;Urologic Oncology: Seminars and Original Investigations;2021-10
4. Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review;Frontiers in Oncology;2021-08-05
5. Peptide‐based therapeutic cancer vaccine: Current trends in clinical application;Cell Proliferation;2021-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3